Cornucopian Capital

United States - Montclair, NJ

• 18/04/2024
• Unknown
• $3,000,000

We believe that the emergence of Medicine 3.0 – predicative, preventative, personalized, and participatory healthcare – presents an untapped opportunity to build companies focused on effectively delivering customized health outcomes in new and innovative ways. These companies – which we call Precision Health Brands™ – will combine new technologies and scientific insight to significantly improve patient-consumer engagement, building the foundation of a new, proactive paradigm for health: whenever possible, prevent disease rather than wait to cure it.

Related People

Aryeh GanzFounder

United States - New York City Metropolitan Area

Investing in preventative health and scientific wellness - I'm building and supporting technology companies that use bio-measurement and personalized data, AI integration and engagement platforms, and bioactive ingredients - to improve healthspan, performance, and longevity.

LinkedIn https://www.linkedin.com/in/aryeh-ganz-9b3085196/